Halaga ng Pagbili
25.33
25.33
25.32
233.06 B
Ang impormasyon tungkol sa nakaraang pagganap ay hindi isang maaasahang tagapagpahiwatig ng pagganap sa hinaharap.
The company's stock has under-performed its sector so far in 2024, while the company managed to beat EPS consensus estimates during the last quarter results. Meanwhile, Pfizer has been increasing its dividend consistently year-over-year for the last 7 years, becoming an attractive stock for dividend income-oriented investors. Additionally, Pfizer has a strong product pipeline that could potentially produce additional revenue streams in the future. Going forward, competition from generic drugs and pricing pressures remain the company's most important headwinds.
Gumawa ng account at kumpletuhin ang isang mabilis na beripikasyon.
Magdagdag ng pera sa iyong wallet sa pamamagitan ng card, bank transfer, o crypto.
Piliin ang PFE, itakda ang halaga, at i-click ang buy o sell — iyon lang!
Pfizer Inc.
PFE
25.325
+0.68%
FAQ